Immunology of cancer stem cells in solid tumours. A review

Vezzoni, 2008, Limitations of the cancer stem cell theory, Cytotechnology, 10.1007/s10616-008-9166-8 Ricci-Vitiani, 2009, Colon cancer stem cells, J Mol Med, 87, 1097, 10.1007/s00109-009-0518-4 Clevers, 2011, The cancer stem cell: premises, promises and challenges, Nat Med, 17, 313, 10.1038/nm.2304 Maugeri-Saccà, 2011, Cancer stem cells and chemosensitivity, Clin Cancer Res, 17, 4942, 10.1158/1078-0432.CCR-10-2538 Dirck, 2008, Stem cell concepts renew cancer research, Blood, 112, 4793, 10.1182/blood-2008-08-077941 Lu, 2012, Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy, Cancer Res, 72, 3451, 10.1158/0008-5472.CAN-11-2536 Li, 2011, Stem cell quiescence, Clin Cancer Res, 17, 4936, 10.1158/1078-0432.CCR-10-1499 Francipane, 2008, Crucial role of interleukin-4 in the survival of colon cancer stem cells, Cancer Res, 68, 4022, 10.1158/0008-5472.CAN-07-6874 Bao, 2008, Targeting cancer stem cells through L1CAM suppresses glioma growth, Cancer Res, 68, 6043, 10.1158/0008-5472.CAN-08-1079 Dihen, 2006, Cancer stem cells and radiotherapy: new insights into tumor radioresistance, J Natl Cancer Inst, 98, 1755, 10.1093/jnci/djj505 Irvin, 2010, T cells enhance stem-like properties and conditional malignancy in gliomas, PLoS One, 5, e10974, 10.1371/journal.pone.0010974 Elleback, 2012, Immunotherapy for metastatic colorectal cancer: present status and new options, Scand J Gastroenterol, 47, 315, 10.3109/00365521.2012.640831 Kalluri, 2009, The basics for epithelial–mesenchymal transition, J Clin Invest, 119, 1420, 10.1172/JCI39104 Magee, 2012, Cancer stem cells: impact, heterogeneity and uncertainty, Cancer Cell, 21, 283, 10.1016/j.ccr.2012.03.003 Lapidot, 1994, A cell initiating human myeloid leukemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0 Bonnet, 1997, Human acute myeloid leukemia is organized as hierarchy that originates from a primitive hematopoietic cell, Nat Med, 3, 730, 10.1038/nm0797-730 Du, 2011, Overexpression of IL-3Ralpha on CD34+CD38− stem cells defines leukemia-initiating cells in Fanconi anemia AML, Blood, 117, 4243, 10.1182/blood-2010-09-309179 Huang, 2009, Aldehyde dehydrogenase 1 is a marker for normal and malignant human colon stem cells (SC) and tracks SC overpopulation during colon tumorigenesis, Cancer Res, 69, 3382, 10.1158/0008-5472.CAN-08-4418 Gerber, 2012, A clinically relevant population of leukemic CD34(+)CD38(−) cells in acute myeloid leukemia, Blood, 119, 3571, 10.1182/blood-2011-06-364182 Cho, 2008, Recent advances in cancer stem cells, Curr Opin Genet Dev, 18, 48, 10.1016/j.gde.2008.01.017 Wakamatsu, 2012, Expression of cancer stem cell markers ALDH1, CD44, and CD133 in primary tumor and lymph node metastasis of gastric cancer, Pathol Int, 62, 112, 10.1111/j.1440-1827.2011.02760.x Luo, 2012, ALDH1Aisozymes are markers of human melanoma stem cells and potential therapeutic targets, Stem cells, 30, 2100, 10.1002/stem.1193 Singh, 2004, Identification of human brain tumor initiating cells, Nature, 432, 396, 10.1038/nature03128 Schneider, 2012, Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker, BMC Cancer, 12, 96, 10.1186/1471-2407-12-96 Hermann, 2007, Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cells, Cell Stem Cells, 1, 313, 10.1016/j.stem.2007.06.002 Tirino, 2009, The role of CD133 in the identification and characterisation of tumor-initiating cells in non-small-cell lung cancer, Eur J Cardiothorac Surg, 36, 446, 10.1016/j.ejcts.2009.03.063 Curley, 2009, CD133 expression defines a tumor initiating cell population in primary human ovarian cancer, Stem Cells, 27, 2875, 10.1002/stem.236 Collins, 2005, Prospective identification of tumorigenic prostate cancer stem cells, Cancer Res, 65, 10946, 10.1158/0008-5472.CAN-05-2018 Chen, 2012, CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells, Int J Biol Sci, 8, 992, 10.7150/ijbs.4454 Dalerba, 2008, Phenotypic characterization of human colorectal cancer stem cells, Proc Natl Acad Sci U S A, 104, 10158, 10.1073/pnas.0703478104 Li, 2007, Identification of pancreatic stem cells, Cancer Res, 67, 1030, 10.1158/0008-5472.CAN-06-2030 Saini, 2012, Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma, PLoS One, 7, e41401, 10.1371/journal.pone.0041401 Kemper, 2010, The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation, Cancer Res, 70, 719, 10.1158/0008-5472.CAN-09-1820 Al Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci U S A, 100, 3983, 10.1073/pnas.0530291100 Schatton, 2008, Identification of cells initiating human melanomas, Nature, 451, 345, 10.1038/nature06489 Du, 2008, CD44 is of functional importance for colorectal cancer stem cells, Clin Cancer Res, 14, 6751, 10.1158/1078-0432.CCR-08-1034 Clay, 2010, Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde hydrogenase, Head Neck, 32, 1195, 10.1002/hed.21315 Choi, 2009, Cancer stem cell markers CD133 and CD24correlate with invasiveness and differentiation in colorectal adenocarcinoma, World J Gastroenterol, 15, 2258, 10.3748/wjg.15.2258 Zhang, 2012, Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis, Cell, 148, 259, 10.1016/j.cell.2011.11.050 Wang, 2012, ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome, Am J Pathol, 180, 1159, 10.1016/j.ajpath.2011.11.015 Yang, 2008, Significance of CD90+ cancer stem cells in human liver cancer, Cancer Cells, 13, 153, 10.1016/j.ccr.2008.01.013 Kong, 2008, CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewed capacity in human B-precursor ALL, Leukemia, 22, 1207, 10.1038/leu.2008.83 Nishizawa, 2012, HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells, Cancer Res, 2012, 2844, 10.1158/0008-5472.CAN-11-3062 Li, 2012, Cancer stem cells: distinct entities or dynamically regulated phenotypes?, Cancer Res, 72, 576, 10.1158/0008-5472.CAN-11-3070 Rosen, 2009, The increasing complexity of the cancer stem cell paradigm, Science, 324, 1670, 10.1126/science.1171837 Takeda, 2011, Interconversion between intestinal stem cell populations in distinct niches, Science, 334, 1420, 10.1126/science.1213214 Roesch, 2010, A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth, Cell, 141, 583, 10.1016/j.cell.2010.04.020 Kim, 2013, Aptamer identification of brain tumor-initiating cells, Cancer Res, 73, 4923, 10.1158/0008-5472.CAN-12-4556 Tu, 2013, MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1, Cancer Res, 73, 6046, 10.1158/0008-5472.CAN-13-0358 Mani, 2008, The epithelial–mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 Podberezin, 2012, Cancer stem cells: a review of potential clinical applications, Arch Pathol Lab Med Li, 2011, C-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype, Proc Natl Acad Scie U S A, 108, 9951, 10.1073/pnas.1016912108 Hjelmeland, 2012, The quest for self-identity: not all cancer stem cells are the same, Clin Cancer Res, 18, 3495, 10.1158/1078-0432.CCR-12-1456 Zorniak, 2012, Differential expression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival, Clin Cancer Res, 18, 3628, 10.1158/1078-0432.CCR-12-0339 Di Tomaso, 2010, Immunobiological characterization of cancer stem cells isolated from glioblastoma patients, Clin Cancer Res, 16, 800, 10.1158/1078-0432.CCR-09-2730 Schatton, 2010, Modulation of T-cell activation by malignant melanoma initiating cells, Cancer Res, 70, 697, 10.1158/0008-5472.CAN-09-1592 Wei, 2010, Glioma-associated cancer-initiating cells induce immunosuppression, Clin Cancer Res, 16, 461, 10.1158/1078-0432.CCR-09-1983 Lottaz, 2010, Transcriptional profiles of CD133+ and CD133− glioblastoma-derived cancer stem cell lines suggest different cells of origin, Cancer Res, 70, 2030, 10.1158/0008-5472.CAN-09-1707 Le Blanc, 2003, Expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells, Exp Hematol, 31, 890, 10.1016/S0301-472X(03)00110-3 Schatton, 2009, Antitumor immunity and cancer stem cells, Ann N Y Acad Sci, 1176, 154, 10.1111/j.1749-6632.2009.04568.x Kim, 2009, Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation, J Neurosci Res, 87, 2264, 10.1002/jnr.22050 Tsuyada, 2012, CCL-2-Mediates cross-talk between cancer cells and sromal fibroblats that regulates breast cancer stem cells, Cancer Res, 72, 2768, 10.1158/0008-5472.CAN-11-3567 Parmiani, 2007, Universal and stemness-related tumor antigens: potential use in cancer immunotherapy, Clin Cancer Res, 13, 5675, 10.1158/1078-0432.CCR-07-0879 Engelmann, 2008, MCF7side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1, Cancer Res, 68, 2419, 10.1158/0008-5472.CAN-07-2249 Hirohashi, 2012, Cytotoxic T lymphocytes. Sniping cancer stem cells, Oncoimmunology, 1, 123, 10.4161/onci.1.1.18075 Segal, 2008, Epitope landscape in breast and colorectal cancer, Cancer Res, 68, 889, 10.1158/0008-5472.CAN-07-3095 Pleasance ED, Cheetham RK, Stephens PI, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. doi: o8658/doi10.1038. Gedye, 2009, Cancer/testis antigens can be immunological targets in clonogenic CD133 melanoma cells, Cancer Immunol Immunother, 58, 1635, 10.1007/s00262-009-0672-0 Koshio, 2013, DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells, Cancer Immunol Immunother, 62, 1619, 10.1007/s00262-013-1467-x Boiko, 2010, Human-melanoma initiating cells express neural crest nerve growth factor receptor CD271, Nature, 466, 10.1038/nature09161 Brown, 2012, Stem-like tumor-initiating cells isolated from IL13Ralpha2 expressing gliomas are targeted and killed by IL-13-zetakine-redirected T cells, Clin Cancer Res, 18, 2199, 10.1158/1078-0432.CCR-11-1669 Schmitz, 2007, Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy, Br J Cancer, 96, 1293, 10.1038/sj.bjc.6603696 Hua, 2011, The CD133+ tumor stem-like cells-associated antigens may elicit highly intense immune response against human malignant glioma, J Neurooncol, 105, 149, 10.1007/s11060-011-0572-y Inoda, 2011, Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells, Am J Pathol, 178, 1805, 10.1016/j.ajpath.2011.01.004 Mitra, 2012, EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell mediated immunotherapy, Mol Vis, 18, 290 Forshew, 2012, Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA, Sci Transl Med, 4, 136ra68, 10.1126/scitranslmed.3003726 Morgan, 2012, Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma, Hum Gene Ther, 23, 1043, 10.1089/hum.2012.041 Avril, 2012, Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells, Brain Pathol, 22, 159, 10.1111/j.1750-3639.2011.00515.x Todaro, 2009, Efficient killing of human colon cancer stem cells by γσT lymphocytes, J Immunol, 182, 7287, 10.4049/jimmunol.0804288 Tallerico, 2013, Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules, J Immunol, 190, 2381, 10.4049/jimmunol.1201542 Pietra, 2009, Natural killer cells kill human melanoma cells with characteristics of cancer stem cells, Int Immunol, 21, 793, 10.1093/intimm/dxp047 Lai, 2012, Human ovarian cancer stem cells can be efficiently killed by γσT lymphocytes, Cancer Immunol Immunother, 61, 979, 10.1007/s00262-011-1166-4 Ning, 2012, Cancer stem cell vaccination confers significant antitumor immunity, Cancer Res, 72, 1853, 10.1158/0008-5472.CAN-11-1400 Visus, 2011, Targeting ALDH (bright) human carcinoma-initiating cells with ALDH1A1-specific CD8+ T cells, Clin Cancer Res, 17, 6174, 10.1158/1078-0432.CCR-11-1111 Glennie, 2005, Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells, Blood, 105, 2821, 10.1182/blood-2004-09-3696 Beyth, 2005, Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness, Blood, 105, 2214, 10.1182/blood-2004-07-2921 Roth, 2010, GDF-15 contributes to proliferation and immune escape of malignant gliomas, Clin Cancer Res, 16, 3851, 10.1158/1078-0432.CCR-10-0705 Noh, 2012, Cancer vaccination drives nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotypes, Cancer Res, 72, 1717, 10.1158/0008-5472.CAN-11-3758 Reim, 2009, Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells, Cancer Res, 69, 8058, 10.1158/0008-5472.CAN-09-0834 Tao, 2012, Expression levels of Fas/FasL mRNA in human brain glioma stem cells, Mol Med Rep, 5, 1202 Schmidt, 2012, Cancer stem cells in the crosshairs, Cancer Discov, 2, 384, 10.1158/2159-8290.CD-ND2012-019 Kepp, 2011, Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy, Cancer Metastasis Rev, 30, 61, 10.1007/s10555-011-9273-4